[go: up one dir, main page]

Fabianowska-Majewska et al., 1994 - Google Patents

Effects of novel anti-viral adenosine analogues on the activity of S-adenosylhomocysteine hydrolase from human liver

Fabianowska-Majewska et al., 1994

Document ID
7529065390721840857
Author
Fabianowska-Majewska K
Duley J
Simmonds H
Publication year
Publication venue
Biochemical pharmacology

External Links

Snippet

Some adenosine analogues have been found previously to inhibit S-adenosylhomocysteine (SAH)-hydrolase activity in erythrocyte lysates. In this study, the enzyme was purified 500- fold from human liver and its M r found to be 190,000. Its kinetics in the synthase direction …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Similar Documents

Publication Publication Date Title
Fabianowska-Majewska et al. Effects of novel anti-viral adenosine analogues on the activity of S-adenosylhomocysteine hydrolase from human liver
Ueland Pharmacological and biochemical aspects of S-adenosylhomocysteine and S-adenosylhomocysteine hydrolase.
Gao et al. Divergent anti-human immunodeficiency virus activity and anabolic phosphorylation of 2 ‘, 3 ‘-dideoxynucleoside analogs in resting and activated human cells.
Roy-Burman Analogues of nucleic acid components: Mechanisms of action
el Kouni et al. Differences in activities and substrate specificity of human and murine pyrimidine nucleoside phosphorylases: implications for chemotherapy with 5-fluoropyrimidines
Brink et al. Metabolic effects of 9-D-arabinosylpurines in ascites tumor cells
Chu et al. Potentiation of 5-fluoro-2′-deoxyuridine antineoplastic activity by the uridine phosphorylase inhibitors benzylacyclouridine and benzyloxybenzylacyclouridine
Nelson Some clinical and pharmacological applications of high-speed liquid chromatography
Bondoc Jr et al. Metabolism of the carbocyclic nucleoside analog carbovir, an inhibitor of human immunodeficiency virus, in human lymphoid cells
Chiang S-Adenosylhomocysteine hydrolase: measurement of activity and use of inhibitors
Cory et al. Leukemia L1210 cell lines resistant to ribonucleotide reductase inhibitors
Huang et al. Phosphorolytic cleavage of 2-fluoroadenine from 9-β-D-arabinofuranosyl-2-fluoroadenine by Escherichia coli: a pathway for 2-fluoro-ATP production
Kierdaszuk et al. Substrate specificity of human deoxycytidine kinase toward antiviral 2prime;, 3′-dideoxynucleoside analogs
Smolenski et al. Effects of adenosine analogues on ATP concentrations in human erythrocytes: further evidence for a route independent of adenosine kinase
Worzalla et al. Pyrazofurin inhibition of purine biosynthesis via 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranosyl 5′-monophosphate formyltransferase
Kazmers et al. Effect of immunosuppressive agents on human T and B lymphoblasts
Chmela et al. In vivo metabolism of 2, 6, 9-trisubstituted purine-derived cyclin-dependent kinase inhibitor bohemine in mice: glucosidation as the principal metabolic route
Schanche et al. Inactivation and reactivation of intracellular S-adenosylhomocysteinase in the presence of nucleoside analogues in rat hepatocytes
Kawahata et al. Inhibition of human lymphoma DNA-dependent RNA polymerase activity by 6-mercaptopurine ribonucleoside triphosphate
Simmonds et al. ATP formation from deoxyadenosine in human erythrocytes: evidence for a hitherto unidentified route involving adenine and S-adenosylhomocysteine hydrolase
Plagemann et al. Mechanism of action of inosine dialdehyde (NSC 118994) in the inhibition of proliferation of tumor cells in culture
Kong et al. Incorporation of the purine moieties of guanosine and inosine analogs into nucleotide pools of human erythrocytes
Gupta et al. Adenosine deaminase in nucleoside synthesis. A review
Kozlowska et al. ATP depletion, purine riboside triphosphate accumulation and rat thymocyte death induced by purine riboside
Nord et al. Inhibition of orotidylate decarboxylase by 4 (5H)-oxo-1-β-d-ribofuranosylpyrazolo [3, 4-d] pyrimidine-3-thiocarboxamide (APR-TC) in B lymphoblasts: Activation by adenosine kinase